← Back to Search

Treatment for Autism Spectrum Disorder

N/A
Recruiting
Research Sponsored by Stalicla SA
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0
Awards & highlights
No Placebo-Only Group

Summary

To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Clinical characterisation of the ASD-Phen1 and ASD-Phen2 subpopulations.
Molecular characterization of the ASD-Phen1 and ASD-Phen2 subpopulations

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Who is running the clinical trial?

Stalicla SALead Sponsor
4 Previous Clinical Trials
268 Total Patients Enrolled
3 Trials studying Autism Spectrum Disorder
248 Patients Enrolled for Autism Spectrum Disorder
Joseph Palumbo, MDStudy DirectorStalicla SA
1 Previous Clinical Trials
15 Total Patients Enrolled
Baltazar Gomez-Mancilla, MD, PhDStudy DirectorStalicla SA
~58 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top